The federal district court held that the insurer was obligated to defend the additional insured, rejecting the insurer’s argument that the additional insured was an indemnitee under the policy’s supplementary payments provision, negating the insurer’s having to pay defense costs.
The Fifty-State Cyclospora Count Is Now 31,972. CDC Has Counted 828 Hospitalizations This Summer and Attributed 454 of Them to the Recalled Lettuce.
This chart stood at 31,521 on Wednesday. Tonight it stands at 31,972. West Virginia and Florida posted new numbers, Michigan reported on Thursday, and one row of my own chart turned out to be short by 31 people. The federal
Biocon Launches Aflibercept Biosimilar in the United States
On August 3, 2026, Biocon Limited announced the commercial launch of its biosimilar YESAFILI (aflibercept-jbvf) in the United States. YESAFILI is a vascular endothelial growth factor (VEGF) inhibitor that is used to treat various ophthalmic conditions. YESAFILI references Regeneron’s EYLEA
Proposed Consent Decree Addressing PFAS at Three Chemours Fluorochemical Facilities Meets Strong Resistance from North Carolina
On June 24, 2026, plaintiffs United States of America and State of West Virginia filed a Complaint and lodged a proposed Consent Decree (“US Consent Decree”) with the Chemours Company and Chemours Company FC, LLC regarding PFAS at three major
What the Supreme Court’s Transgender Sports Ruling Means for Education Institutions
On June 30, 2026, the United States Supreme Court decided the consolidated cases West Virginia v. B.P.J. (No. 24-43) and Little v. Hecox (No. 24-38), upholding state laws in West Virginia and Idaho that prohibit transgender female athletes from participating
Decision Alert: Supreme Court Upholds State Laws Governing Participation on Women’s and Girls’ Athletic Teams Based on Biological Sex
On June 30, 2026, the final day opinions in argued cases for the October 2025 Term were issued, the Court held in West Virginia v. B.P.J. (No. 24-43) and Little v. Hecox (No. 24-38) that state laws limiting participation on
United States Supreme Court Holds that States May Restrict Transgender Student Participation in Female Sports
On June 30, 2026, the United States Supreme Court issued its decision in West Virginia v. B.P.J. and the companion case Little v. Hecox, holding that Title IX and the Equal Protection Clause permit states to restrict participation in girls’ and women’s sports
Conflicts — Judge’s Mediator Must Recuse in Subsequent Matters, Co-Conspirator Representation Ruled Conflict
David Kluft asks: “Can I represent co-conspirators in a drug distribution criminal case?” —
- “A VA attorney was appointed to represent Defendant A, who was alleged to have traveled to WV to purchase illegal drugs from Defendant B,
Fourth Circuit Raises the Bar for PFAS Injunctions in Citizen Suits
Businesses facing PFAS compliance challenges received an important victory in a court decision this month when the U.S. Court of Appeals for the Fourth Circuit vacated a preliminary injunction that had barred The Chemours Company from discharging PFAS compounds above
Fourth Circuit Clarifies Irreparable Harm Showing Required to Obtain Preliminary Injunction to Prevent PFAS Discharges in Excess of Permit Limits
Fourth Circuit Clarifies Irreparable Harm Showing Required to Obtain Preliminary Injunction to Prevent PFAS Discharges in Excess of Permit Limits
In West Virginia Rivers Coalition, Inc., et al. v. The Chemours Company FC, LLC, the Court of Appeals for the